Sallis–Beighton syndrome
Sallis–Beighton syndrome is a rare genetic disorder that affects multiple systems of the body. It is characterized by a combination of symptoms and physical findings that may vary greatly in range and severity from case to case. The syndrome is named after the researchers who first described it.
Symptoms and Characteristics[edit]
Sallis–Beighton syndrome is primarily known for its impact on the connective tissue, leading to symptoms such as hypermobility of the joints, skin that may be stretchy and fragile, and a tendency towards bruising easily. Individuals with this syndrome may also exhibit features that overlap with other connective tissue disorders, making diagnosis challenging.
Genetic Aspect[edit]
The exact genetic mutation responsible for Sallis–Beighton syndrome has not been fully identified, making it difficult to understand the inheritance pattern. However, it is believed to be autosomal dominant, meaning that only one copy of the altered gene in each cell is sufficient to cause the disorder. This suggests that a person with Sallis–Beighton syndrome has a 50% chance of passing the condition on to their offspring.
Diagnosis[edit]
Diagnosis of Sallis–Beighton syndrome is primarily clinical, based on the presence of characteristic symptoms and family history. Genetic testing may be helpful in confirming the diagnosis but is not always conclusive due to the current limitations in understanding the genetic basis of the syndrome.
Treatment and Management[edit]
There is no cure for Sallis–Beighton syndrome, and treatment is symptomatic and supportive. Management may include physical therapy to strengthen muscles and improve joint stability, as well as measures to protect the skin and prevent injury. In some cases, surgery may be necessary to correct joint problems or other physical abnormalities associated with the syndrome.
Prognosis[edit]
The prognosis for individuals with Sallis–Beighton syndrome varies depending on the severity of symptoms and the effectiveness of management strategies. With appropriate care, most individuals can lead active, fulfilling lives.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
